# Super Vision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/super-vision-2

- Industry: Healthcare Specialists
- Headquarters: Shanghai, China
- Latest round: Series A (Dec 16, 2024)
- Investors on record: 1

## About

Founded in 2021 and based in Shanghai, China, Super Vision operates as an ophthalmic medical service company that focuses on providing adult myopia surgery and adolescent myopia prevention and control services. It has 3 medical institutions in the country. In December 2024, Super Vision closed a series A+ funding.

The company's main business is ophthalmic surgery and myopia prevention and control. Its adult refractive surgery includes Implantable Collamer Lens (ICL) and Laser Assisted in - Situ Keratomileusis (LA). The company also provides adolescent myopia prevention and control, as well as optometry services.

The company generates revenue by providing adult myopia surgery and adolescent myopia prevention and control services.

The company will use the series A+ funding to expand its ophthalmic medical services.

## Funding rounds

- Series A, Dec 16, 2024 — Dalton Venture

## Investors

- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A